Atrys Health, S.A.

Equities

ATRY

ES0105148003

Healthcare Facilities & Services

Market Closed - BME Other stock markets 11:35:26 2024-04-26 am EDT			5-day change	1st Jan Change
2.88 ^EUR	-0.35%		-2.37%	-21.53%

Mar. 26	Atrys Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Atrys Health, S.A. announced that it has received ?13.3 million in funding	CI

Atrys Health, S.A. acquired ChileRad for €9.35 million.

December 26, 2022

Atrys Health, S.A. (BME:ATRY) acquired ChileRad for €9.35 million on December 27, 2022. Atrys Health has an equity value of €8.5 million and an earnout payment of €0.85 million. Pablo Undurraga and Santiago Achurra of ACU Abogados acted as legal advisor to the sellers. Marcos Ríos of Carey y Cía. Ltda. acted as legal advisor to Atrys Health, S.A. and Guillermo Guerra, Jacobo Palanca and Emiliano Moreno of Gómez-Acebo & Pombo Abogados, S.L.P. acted as legal advisor to Atrys Health, S.A.

Atrys Health, S.A. (BME:ATRY) completed the acquisition of ChileRad on December 27, 2022.

Latest news about Atrys Health, S.A.

Atrys Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
Atrys Health, S.A. announced that it has received ?13.3 million in funding	Dec. 27	CI
Atrys Health Closes EUR35 Million Sale of 75% Stake in Professional Group Conversia	Dec. 14	MT
Arraigo Midco Sl acquired a 75% stake in Professional Group Conversia, S.L.U from Atrys Health, S.A. for ?35 million.	Dec. 12	CI
Atrys Health, S.A. announced that it expects to receive ?25 million in funding	Nov. 19	CI
Atrys Health, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-29	CI
Atrys Health, S.A. acquired Chaxa Radiology.	23-06-14	CI
Atrys Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-28	CI
Spain's Atrys Health to Buy Chilean Teleradiology Services Providers for EUR8 Million	22-12-27	MT
Atrys Health Buys Spanish Cancer Care Provider Initia Oncología	22-12-27	MT
Atrys Health, S.A. acquired Initia Oncologia, Slp.	22-12-27	CI
Atrys Health, S.A. acquired 70% stake in Initia Research.	22-12-27	CI
Atrys Health, S.A. acquired ChileRad for €9.35 million.	22-12-26	CI
Atrys Health, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-30	CI
Juan María Riberas Mera acquired a 5.432% stake in Atrys Health, S.A. for €28 million.	22-06-20	CI
Atrys Health, S.A. acquired Significant Impact Systems SL from Nexxus Iberia Private Equity Fund I, FCR, a fund managed by Nexxus Iberia SGEIC S.A. for €94.47 million.	22-06-12	CI
Atrys Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
Atrys Health Wins Nod to List Shares on Main Spanish Stock Market	22-02-03	MT
Atrys Health, S.A. acquired Simm Molecular from Isabel Roca and Joan Castell for €6 million.	22-01-03	CI
Atrys Health, S.A. signed an agreement to acquire Simm Molecular from Isabel Roca and Joan Castell for €6 million.	21-12-15	CI
Atrys Health, S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	21-10-29	CI
Medical Properties Trust, Inc. acquired cancer treatment and diagnostics center near Porto from Atrys Health, S.A. for €18 million.	21-10-27	CI
Atrys Health, S.A. completed the acquisition of GENETYCA – ICM, S.A.	21-08-31	CI
Atrys Health, S.A. signed an agreement to acquire Genetyca.	21-06-06	CI
An unknown buyer acquired 5% stake in Atrys Health, S.A. from Inversiones Industriales Serpis S.L.	21-05-10	CI

Chart Atrys Health, S.A.

Duration

Period

More charts

Company Profile

Atrys Health SA, formerly Europath Biosciences SL, is Spain-based company primarily engaged in the predictive and personalized oncology therapies. It operates under Atrys brand name. Atrys is a clinical and translational research laboratory dedicated to the diagnosis, prognosis and treatment of cancer, including hematologic and solid malignancies. It has four areas of activity: Laboratory, Telemedicine, Radiotherapy, as well as Research and Development (R&D). The Company has its diagnostic laboratories and translational research in Barcelona and Granada, and offices in Madrid, Spain.

Sector

Healthcare Facilities & Services

More about the company

Income Statement Evolution

More financial data

Ratings for Atrys Health, S.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.88 EUR

Average target price

6.61 EUR

Spread / Average Target

+129.51%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
ATRYS HEALTH, S.A.	-21.53%	233M
CVS HEALTH CORPORATION	-14.92%	84.68B
HCA HEALTHCARE, INC.	+13.30%	81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+11.62%	29.59B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.71%	16.73B
FRESENIUS SE & CO. KGAA	-3.06%	16.36B
QUEST DIAGNOSTICS INCORPORATED	-2.63%	14.92B
PURE HEALTH HOLDING	-31.75%	11.77B
FRESENIUS MEDICAL CARE AG	-1.42%	11.72B
DAVITA INC.	+27.44%	11.71B

Other Healthcare Facilities & Services